Effect of different dosages of hydrochloride pioglitazone on the excretion of urinary podocalyxin in STZ-induced diabetic rats

XING Yan,YE Shan-dong,CHEN Yu-mi,CHEN Y

DOI: https://doi.org/10.3969/j.issn.1006-6187.2013.02.024

2013-01-01

Abstract:Objective To observe the effect of different dosages of hydrochloride pioglitazone(PIO) on the excretion of urinary podocalyxin(PCX) in STZ-induced diabetic rats.Methods Diabetic rats were randomized into the following four groups: diabetic rats without treatment(Model group,n=8),and PIO 10,20,and 30 mg/(kg·d) groups(DR1,DR2,and DR3 groups,n=8 in each) treated by intragastric administration.UAlb,Cr,and urinary PCX were measured on the first day and at the end of the 4th and 8th weeks respectively.Results(1) At the end of the 4th week,compared with the model group,the level of urinary albumin-to-creatinine ratio(UACR) was significantly decreased in both DR2 and DR3 groups(P<0.01).However,there was no statistical difference in the level of urinary podocalyxin-to-creatinine ratio(UPCR) among the four groups.(2) At the end of the 8th week,compared with the model group,the level of UPCR was significantly reduced in both groups DR2 and DR3(P<0.01),there was no statistical difference between the DR1 and model groups.The level of UACR was significantly lower in the PIO groups than in the model group(P<0.01),while the level of UACR was significantly lower in the DR2 and DR3 groups than in the DR1 group(P<0.05).(3) UPCR was positively correlated with UACR(r=0.86,P<0.01).Conclusion PIO can restrain the loss of PCX in the urine with a dose and time dependent manner,which may play a protective role for the kidney in STZ-induced diabetic rats.